Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02275845
PHASE3

Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus

Sponsor: Maasstad Hospital

View on ClinicalTrials.gov

Summary

Metformin vs Control to prevent gestational diabetes mellitus (GDM) in women with a high risk for GDM, an open label randomized controlled trial' The Medico-GDM trial

Official title: Metformin vs Control to Prevent Gestational Diabetes Mellitus (GDM) in Women With a High Risk for GDM, an Open Label Randomized Controlled Trial, The Medico-GDM Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

400

Start Date

2014-10-08

Completion Date

2017-03-03

Last Updated

2026-10-09

Healthy Volunteers

Yes

Interventions

DRUG

Metformin

Metformin twice daily 500 mg for the first week, after that twice daily 1000 mg (from 14 weeks pregnancy untill delivery)

OTHER

control diet

2000 calories/day diet, with an adequate distribution of carbohydrates during the day

Locations (1)

Maasstad Ziekenhuis

Rotterdam, Netherlands